About this trial
ZhenQi FuZheng granules has been used to improve the immune function of human body, protect the bone marrow and adrenal cortex function and promote the recovery of positive function in traditional Chinese medicine care, especially with the immune imbalance diseases like post-surgery, chemotherapy and rhinitis. This project intends to establish AR(allergic rhinitis)specimen library, cell and animal model experiment, combining clinical cohort research with applied basic research, further assess the therapeutic mechanism of ZhenQiFuZheng granules in AR. We assume that ZhenQi FuZheng granules could cause the metabolic omics changes of nasal inflammatory factors and nasal secretions in AR patients, thus improving the type 2 inflammation level of allergic rhinitis.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Adult patients (18-65 years).
Patients who visited the Department of Otolaryngology of the First Affiliated Hospital of Nanjing Medical University and are diagnosed as allergic rhinitis .
Disqualifiers
Patients who refused to accept specimen and questionnaire collection.
Patients who had nasal diseases other than allergic rhinitis, such as nasal papilloma and nasal malignant tumor.
Trial design
Single group
Treatments tested in this trial
ZhenQi FuZheng granules (ShiDaiYangGuang)
Drug1 bag at a time, twice a day. Oral orally for 4 weeks.
Treatment groups
Trial outcomes
Primary outcomes
Rhinoconjunctivitis Quality of Life Questionnaire
Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure
Visual Analog Score for pain
Patients were scored by questionnaire before and after treatment, and the change in score before and after treatment was the primary outcome measure
Sponsors and contacts
Click on the lead sponsor to view all of their trials.